登录新浪财经APP 搜索【信披】查看更多考评等级 每天三分钟 公告很轻松 德明利：拟募资不超32亿元 用于固态硬盘、内存产品扩产项目等；上纬新材：选举彭志辉为公司董事 长；富森美：副总经理、董事会秘书张凤术被立案调查并实施留置措施；君亭酒店：控股股东筹划公司 控制权变更 26日起停牌…… 聚焦一：德明利：拟募资不超32亿元 用于固态硬盘、内存产品扩产项目等 公司计划向特定对象发行股票，发行对象不超过35名，且所有发行对象均以现金方式认购，发行数量不 超过6806.59万股(含本数)。募集资金总额不超过32亿元，将用于固态硬盘（SSD）扩产项目、内存产品 （DRAM）扩产项目、德明利智能存储管理及研发总部基地项目以及补充流动资金。 聚焦二：上纬新材：选举彭志辉为公司董事长 2025年11月25日，公司召开第四届董事会第一次会议，全体董事一致同意选举彭志辉担任公司第四届董 事会董事长，并选举产生第四届审计委员会、战略与可持续发展委员会、提名与薪酬考核委员会。 聚焦三：富森美：副总经理、董事会秘书张凤术被立案调查并实施留置措施 公司近日收到崇州市监察委员会签发的《立案通知书》和《留置通知书》，对公司副总经理、董事会 ...

Fundraising and Expansion Plans - Demingli plans to raise no more than 3.2 billion yuan for the expansion of solid-state drives and memory products, including a smart storage management and R&D headquarters project [1] - Nuo Puxin intends to issue A-shares to raise no more than 1.45 billion yuan for blueberry base expansion and international R&D center projects [4] - Anglikang aims to raise no more than 1.16 billion yuan for innovative drug R&D and industrialization projects [5] Management Changes - Shangwei New Materials elected Peng Zhihui as the chairman of the fourth board of directors [2] - Fusenmei's vice president and board secretary Zhang Fengshu is under investigation, with operations expected to remain normal [3] Mergers and Acquisitions - Guosheng Technology plans to acquire 100% equity of Fuyue Technology for 240.6 million yuan, which will positively impact the company's development [6] - China Aluminum's subsidiary Yun Aluminum plans to acquire stakes in three aluminum companies for a total of 2.27 billion yuan [12] Share Transfers and Control Changes - Xinyaqiang's controlling shareholder transferred 94,420,253 shares at 20.76 yuan per share, totaling 1.96 billion yuan, changing the controlling shareholder to a private equity fund [7] - Junting Hotel's controlling shareholder is planning a change in control, leading to a temporary stock suspension [8] Investments and Strategic Initiatives - Dayang Electric is investing 10 million yuan in a private equity fund focused on robotics, enhancing its strategic positioning in the industry [13] - Huashi Technology is increasing its investment in a robotics company to expand its AI application scenarios [14] Stock Buybacks and Shareholder Actions - Century Huatong has secured a loan commitment of up to 900 million yuan for stock repurchase [12] - Wanrun shares' controlling shareholder plans to increase holdings between 365 million and 730 million yuan to boost investor confidence [15]

格隆汇11月25日丨三星医疗(601567.SH)公布，公司下属全资子公司宁波奥克斯智能科技股份有限公司 （简称"奥克斯智能科技"）于近日在国家电网有限公司2025年东北区域第二次联合采购架空绝缘导线、 10kV变压器、10kV柱上变压器台成套设备协议库存招标采购项目中被推荐为中标候选人，预计合计中 标总金额约为10,659.93万元。 ...

三星医疗（601567）(601567.SH)发布公告，公司下属全资子公司宁波奥克斯智能科技股份有限公司(简 称"奥克斯智能科技")于近日在国家电网有限公司2025年东北区域第二次联合采购架空绝缘导线、10kV 变压器、10kV柱上变压器台成套设备协议库存招标采购项目中被推荐为中标候选人，预计合计中标总 金额约为1.07亿元。 ...

智通财经APP讯，三星医疗(601567.SH)发布公告，公司下属全资子公司宁波奥克斯智能科技股份有限 公司(简称"奥克斯智能科技")于近日在国家电网有限公司2025年东北区域第二次联合采购架空绝缘导 线、10kV变压器、10kV柱上变压器台成套设备协议库存招标采购项目中被推荐为中标候选人，预计合 计中标总金额约为1.07亿元。 ...

Core Viewpoint - Samsung Medical has been recognized as a candidate for a major procurement project by the State Grid Corporation of China, with an expected total bid amount of approximately 168 million yuan, which will strengthen its position in the domestic power grid market and drive annual performance growth [1][2]. Group 1: Recent Achievements - Samsung Medical's subsidiary, Aixs Intelligent Technology, has been recommended as a candidate for a procurement project that includes key electrical equipment such as overhead insulated wires and 10KV transformers [1][2]. - Since 2025, Samsung Medical has secured significant orders, with a total order backlog of 17.914 billion yuan as of the end of the third quarter of 2025, representing a year-on-year increase of 14.69% [1][2]. Group 2: Financial Performance - The company reported revenues of 9.098 billion yuan, 11.46 billion yuan, and 14.6 billion yuan for the years 2022 to 2024, with year-on-year growth rates of 29.55%, 25.99%, and 27.38% respectively [4][5]. - In the first three quarters of 2025, the company achieved revenue of 11.08 billion yuan, a year-on-year increase of 6.19%, but the net profit attributable to shareholders decreased by 15.85% to 1.528 billion yuan [5]. Group 3: Research and Development - Samsung Medical has invested heavily in R&D, with total R&D expenses exceeding 2.037 billion yuan over the past five years, which has strengthened its technological capabilities and product competitiveness [4][6]. - The company has received 32 automation patents in the last three years and is advancing its "smart manufacturing" strategy, including the establishment of the industry's first digital factory [6].

Key Points - Rongbai Technology has signed a cooperation agreement with CATL, becoming its primary supplier of sodium battery cathode materials, with a commitment to supply at least 60% of CATL's total procurement volume if certain conditions are met [4] - Maihe Co.'s chairman and actual controller has been placed under investigation, with the general manager taking over the chairman's responsibilities [5] - Fudan Microelectronics will see Guosheng Investment become its largest shareholder after acquiring 12.99% of its shares [6][7] - Guolian Minsheng has received approval for stock option market-making business from the China Securities Regulatory Commission [8] - Luoping Zinc & Electric's subsidiary has received approval to resume production at its lead-zinc mine [9] - Heshun Petroleum's actual controller plans to transfer 6% of the company's shares through an agreement, with no change in control expected [10] - Furi Co. has stated that it currently has no plans for capacity expansion despite stock price fluctuations [11] - Joyoung Co. clarified that it operates in the small home appliance sector and does not engage in food and beverage production [12] - Huaxia Happiness reported abnormal stock trading but confirmed no undisclosed major events aside from a pre-restructuring notice [13] - Zhongsheng Pharmaceutical is advancing several clinical trials, but the outcomes remain uncertain [14] - Pingtan Development noted that its stock price has risen sharply without significant changes in fundamentals, indicating potential market overreaction [15] Shareholding Changes - Chahua Co.'s major shareholder plans to reduce its stake by up to 3% [16] - Qianli Technology's shareholder intends to reduce its stake by up to 2% [17] - Gaoling Information's shareholders plan to collectively reduce their stake by up to 1.5% [18] - Guochuang High-tech's major shareholder plans to reduce its stake by up to 1% [19] - China Aluminum's director plans to reduce a very small percentage of shares [20] - Shikong Technology plans to reduce up to 0.29% of its repurchased shares [21] - Xinong Co.'s director plans to reduce up to 0.1925% of shares [22] - Yifeng Pharmacy's vice presidents plan to reduce a total of 213,900 shares [23] Major Contracts - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 168.12 million yuan [24]

证券日报网讯 11月16日晚间，三星医疗发布公告称，下属全资子公司奥克斯智能科技在国家电网有限 公司2025年华北区域第二次联合采购架空绝缘导线、10KV变压器、10KV柱上变压器台成套设备协议库 存招标采购项目中被推荐为中标候选人，预计合计中标总金额约为16，812.83万元。 （编辑 王江浩） ...

Group 1 - Rongbai Technology signed a cooperation agreement with CATL, making Rongbai the primary supplier of sodium battery cathode powder, with a commitment to purchase at least 60% of its total procurement volume annually, potentially reaching 500,000 tons [3] - Meihe Co.'s controlling shareholder and chairman Wang Jinping is under investigation and has been placed under detention, with the general manager Zhang Kaixu taking over the chairman's responsibilities [4] - Fudan Microelectronics announced that Guosheng Investment plans to acquire 12.99% of its shares from Fuxin Fangao, making Guosheng the largest shareholder post-transfer [5] Group 2 - Guolian Minsheng received approval for stock option market-making business from the China Securities Regulatory Commission [6] - Luoping Zinc Electric's subsidiary has received approval to resume production at the Jinpo lead-zinc mine, having met safety and operational requirements [7] - Heshun Petroleum's actual controller and associates plan to transfer 6% of the company's shares through an agreement, maintaining control post-transfer [8] Group 3 - Furi Co. stated that there are currently no expansion plans for its new energy sector, amid stock price volatility and potential irrational speculation [9] - Joyoung Co. clarified that it operates in the small home appliance sector and does not engage in food and beverage production, despite recent market speculation [10][11] - Huaxia Happiness reported abnormal stock trading but confirmed no undisclosed significant matters aside from its pre-restructuring announcement [12] Group 4 - Zhongsheng Pharmaceutical is advancing several clinical trials for its innovative drugs, but the outcomes remain uncertain, including the approval and market competition for its products [13] - Pingtan Development noted that its stock price has risen sharply without significant changes in fundamentals, indicating potential market overreaction [14] Group 5 - Chahua Co. announced that its major shareholder plans to reduce its stake by up to 3% within three months [16] - Qianli Technology's major shareholder intends to reduce its stake by up to 2% through a targeted sale [17] - Gaoling Information's shareholders plan to collectively reduce their holdings by up to 1.5% due to funding needs [18] Group 6 - Guochuang High-tech's major shareholder plans to reduce its stake by up to 1% within three months [19][20] - China Aluminum's director plans to sell a minimal stake of 0.00034% due to personal funding needs [21] - Shikong Technology plans to reduce its repurchased shares by up to 0.29% [22] Group 7 - Xinong Co.'s director plans to reduce his stake by up to 0.1925% due to personal funding needs [23] - Yifeng Pharmacy's vice presidents plan to collectively reduce their holdings by up to 213,900 shares due to personal funding needs [24] Group 8 - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid, with an estimated total bid amount of approximately 168.12 million yuan [26]

格隆汇11月16日丨三星医疗(601567.SH)发布公告，公司下属全资子公司宁波奥克斯智能科技股份有限 公司(以下简称"奥克斯智能科技")于近日在国家电网有限公司2025年华北区域第二次联合采购架空绝缘 导线、10KV变压器、10KV柱上变压器台成套设备协议库存招标采购项目中被推荐为中标候选人，预计 合计中标总金额约为16,812.83万元。 ...